10 research outputs found
Mimicking Red Blood Cell Lipid Membrane To Enhance the Hemocompatibility of Large-Pore Mesoporous Silica
Mesoporous silica nanoparticles (MSNs)
have been repeatedly demonstrated
as potential drug-delivery devices. The study of biocompatibility
and interaction of these materials with the various cell types is
of great interest with regard to the development of viable pharmaceutical
products. By mimicking the cholesterol, phosphatidylcholine, and phosphatidylethanolamine
composition of the outer leaflet of a human red blood cell (RBC),
lipid-bilayer-coated mesoporous silica particles show considerably
improved hemocompatibility over phosphatidylcholine-coated and uncoated
large-pore MSN (<i>l</i>-MSN). These inorganic/organic composite
nanomaterials are shown to be capable of interfacing with RBCs without
damaging the cells even at relatively high concentrations, as observed
through electron microscopy, UV–vis spectroscopy, and flow
cytometry analyses. Interestingly, the absence of cholesterol in the
outer bilayer composition is shown to produce toxic effects without
resulting in hemolysis. By maintaining the ζ potential of lipid-bilayer-functionalized
MSNs similar to that of the hemolytic <i>l</i>-MSNs, we
demonstrate that the bilayer composition, and not the surface charge,
plays a significant role in determining the hemocompatibility of MSN-based
materials
Monitoring the Stimulated Uncapping Process of Gold-Capped Mesoporous Silica Nanoparticles
To
establish a new method for tracking the interaction of nanoparticles
with chemical cleaving agents, we exploited the optical effects caused
by attaching 5–10 nm gold nanoparticles with molecular linkers
to large mesoporous silica nanoparticles (MSN). At low levels of gold
loading onto MSN, the optical spectra resemble colloidal suspensions
of gold. As the gold is removed, by cleaving agents, the MSN revert
to the optical spectra typical of bare silica. Time-lapse images of
gold-capped MSN stationed in microchannels reveal that the rate of
gold release is dependent on the concentration of the cleaving agent.
The uncapping process was also monitored successfully for MSN endocytosed
by A549 cancer cells, which produce the cleaving agent glutathione.
These experiments demonstrate that the optical properties of MSN can
be used to directly monitor cleaving kinetics, even in complex cellular
settings
Monitoring the Stimulated Uncapping Process of Gold-Capped Mesoporous Silica Nanoparticles
To
establish a new method for tracking the interaction of nanoparticles
with chemical cleaving agents, we exploited the optical effects caused
by attaching 5–10 nm gold nanoparticles with molecular linkers
to large mesoporous silica nanoparticles (MSN). At low levels of gold
loading onto MSN, the optical spectra resemble colloidal suspensions
of gold. As the gold is removed, by cleaving agents, the MSN revert
to the optical spectra typical of bare silica. Time-lapse images of
gold-capped MSN stationed in microchannels reveal that the rate of
gold release is dependent on the concentration of the cleaving agent.
The uncapping process was also monitored successfully for MSN endocytosed
by A549 cancer cells, which produce the cleaving agent glutathione.
These experiments demonstrate that the optical properties of MSN can
be used to directly monitor cleaving kinetics, even in complex cellular
settings
Universal and Versatile Route for Selective Covalent Tethering of Single-Site Catalysts and Functional Groups on the Surface of Ordered Mesoporous Carbons
A universal and benign strategy for
the surface functionalization
of OMCs through lithium-mediated chemistry has been reported. For
this purpose, a hard templating method for the facile synthesis of
monodispersed ordered mesoporous carbons (OMCs) with well-defined
morphology templated from large pore mesoporous silica nanoparticles
(<i>l-</i>MSN) has been used. These OMCs have high surface
areas (800–1000 m<sup>2</sup>g<sup>–1</sup>) and large
pore sizes (4–6 nm) suitable for anchoring bulky inorganic
complexes. It has been demonstrated that the numerous defect sites
present in the graphitic structure of OMCs can be effectively utilized
for selective and covalent tethering of functional groups and single-site
catalysts through lithiation of OMCs. Accordingly, for the first time
a copper-based single-site oxidation catalyst has been covalently
anchored onto the surface of OMCs. This novel system has been thoroughly
characterized with advanced techniques such as electron microscopy,
Raman spectroscopy, thermogravimetric analysis, X-ray diffraction,
and acid–base titrations along with structural insights regarding
the tethered copper catalyst by X-ray photoelectron spectroscopy.
As a proof-of-principle, this active catalytic system has been used
to demonstrate environmentally benign, room temperature selective
oxidation of benzyl alcohol. We envision that this strategy for surface
functionalization would be universal and can be applied for tethering
a variety of different single-site catalysts onto OMCs with high surface
areas. We also believe that it would have a direct impact on the currently
available limited syntheses and surface functionalization techniques
of mesoporous carbons for catalytic, electrocatalytic, and biological
applications
Solvent-Induced Reversal of Activities between Two Closely Related Heterogeneous Catalysts in the Aldol Reaction
The relative rates of the aldol reaction catalyzed by
supported
primary and secondary amines can be inverted by 2 orders of magnitude,
depending on the use of hexane or water as a solvent. Our analyses
suggest that this dramatic shift in the catalytic behavior of the
supported amines does not involve differences in reaction mechanism,
but is caused by activation of imine to enamine equilibria and stabilization
of iminium species. The effects of solvent polarity and acidity were
found to be important to the performance of the catalytic reaction.
This study highlights the critical role of solvent in multicomponent
heterogeneous catalytic processes
Palladium Intercalated into the Walls of Mesoporous Silica as Robust and Regenerable Catalysts for Hydrodeoxygenation of Phenolic Compounds
Nanostructured noble-metal catalysts
traditionally suffer from
sintering under high operating temperatures, leading to durability
issues and process limitations. The encapsulation of nanostructured
catalysts to prevent loss of activity through thermal sintering, while
maintaining accessibility of active sites, remains a great challenge
in the catalysis community. Here, we report a robust and regenerable
palladium-based catalyst, wherein palladium particles are intercalated
into the three-dimensional framework of SBA-15-type mesoporous silica.
The encapsulated Pd active sites remain catalytically active as demonstrated
in high-temperature/pressure phenol hydrodeoxygenation reactions.
The confinement of Pd particles in the walls of SBA-15 prevents particle
sintering at high temperatures. Moreover, a partially deactivated
catalyst containing intercalated particles is regenerated almost completely
even after several reaction cycles. In contrast, Pd particles, which
are not encapsulated within the SBA-15 framework, sinter and do not
recover prior activity after a regeneration procedure
Aerobic Epoxidation of Olefin by Platinum Catalysts Supported on Mesoporous Silica Nanoparticles
We report platinum
catalysts for the efficient aerobic oxidation
of olefins to form epoxides and/or derived glycol monoethers. The
catalystsî—¸diaqua and dichloro Pt<sup>II</sup> complexes supported
by the ligand diÂ(2-pyridine)Âmethanesulfonate (dpms)î—¸are most
active when they are covalently tethered to mesoporous silica nanoparticles
(MSNs). Supporting the molecular Pt complexes on the MSNs prevents
bimolecular catalyst deactivation. Using this strategy, >40 000
turnovers are achieved for the aerobic oxidation of norbornene in
2,2,2-trifluoroethanol. The position of the tether and the nature
of other ligands in the metal coordination sphere (aqua, hydroxo,
or chloro) are shown to affect the catalyst activity. The new MSN-supported
Pt materials were characterized by nuclear magnetic resonance (NMR)
spectroscopy, nitrogen physisorption, powder X-ray diffraction (PXRD),
scanning electron microscopy (SEM), transmission electron microscopy
(TEM), and thermogravimetric analysis (TGA)
Organometallic Complexes Anchored to Conductive Carbon for Electrocatalytic Oxidation of Methane at Low Temperature
Low-temperature
direct methane fuel cells (DMEFCs) offer the opportunity to substantially
improve the efficiency of energy production from natural gas. This
study focuses on the development of well-defined platinum organometallic
complexes covalently anchored to ordered mesoporous carbon (OMC) for
electrochemical oxidation of methane in a proton exchange membrane
fuel cell at 80 °C. A maximum normalized power of 403 μW/mg
Pt was obtained, which was 5 times higher than the power obtained
from a modern commercial catalyst and 2 orders of magnitude greater
than that from a Pt black catalyst. The observed differences in catalytic
activities for oxidation of methane are linked to the chemistry of
the tethered catalysts, determined by X-ray photoelectron spectroscopy.
The chemistry/activity relationships demonstrate a tangible path for
the design of electrocatalytic systems for C–H bond activation
that afford superior performance in DMEFC for potential commercial
applications
Conserved Activity of Reassociated Homotetrameric Protein Subunits Released from Mesoporous Silica Nanoparticles
Mesoporous
silica nanoparticles (MSN) with enlarged pores were
prepared and characterized, and reversibly dissociated subunits of
concanavalin A were entrapped in the mesopores, as shown by multiple
biochemical and material characterizations. When loaded in the MSN,
we demonstrated protein stability from proteases and, upon release,
the subunits reassociated into active proteins shown through mannose
binding and <i>o</i>-phthalaldehyde fluorescence. We have
demonstrated a versatile and facile method to load homomeric proteins
into MSN with potential applications in enhancing the delivery of
large therapeutic proteins